$REGN
Regeneron Pharmaceuticals Inc

2018 Q3 Form 10-Q Financial Statement

#000153217618000036 Filed on November 06, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $1.664B $1.501B
YoY Change 10.85% 22.99%
Cost Of Revenue $110.4M $46.39M
YoY Change 137.99% 55.14%
Gross Profit $1.553B $1.454B
YoY Change 6.79% 22.19%
Gross Profit Margin 93.36% 96.91%
Selling, General & Admin $369.2M $306.8M
YoY Change 20.35% 13.6%
% of Gross Profit 23.77% 21.09%
Research & Development $557.0M $529.7M
YoY Change 5.14% -2.45%
% of Gross Profit 35.86% 36.43%
Depreciation & Amortization $35.40M $37.80M
YoY Change -6.35% 35.97%
% of Gross Profit 2.28% 2.6%
Operating Expenses $926.2M $836.5M
YoY Change 10.72% 2.88%
Operating Profit $626.9M $559.9M
YoY Change 11.96% 54.33%
Interest Expense $7.400M $6.182M
YoY Change 19.7% -1346.37%
% of Operating Profit 1.18% 1.1%
Other Income/Expense, Net $9.000M $5.679M
YoY Change 58.48% 84.44%
Pretax Income $635.9M $565.6M
YoY Change 12.43% 54.59%
Income Tax $41.20M $177.3M
% Of Pretax Income 6.48% 31.34%
Net Earnings $594.7M $388.3M
YoY Change 53.15% 46.64%
Net Earnings / Revenue 35.75% 25.88%
Basic Earnings Per Share $5.50 $3.64
Diluted Earnings Per Share $5.17 $3.32
COMMON SHARES
Basic Shares Outstanding 108.0M shares 106.7M shares
Diluted Shares Outstanding 115.1M shares 117.0M shares

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.192B $1.379B
YoY Change 58.96% -2.06%
Cash & Equivalents $1.088B $792.1M
Short-Term Investments $1.104B $587.0M
Other Short-Term Assets $644.0M $357.0M
YoY Change 80.39% 99.44%
Inventory $1.040B $641.6M
Prepaid Expenses
Receivables $1.666B $1.533B
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.720B $4.136B
YoY Change 38.3% 18.11%
LONG-TERM ASSETS
Property, Plant & Equipment $2.524B $2.275B
YoY Change 10.99% 21.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.874B $1.327B
YoY Change 41.22% 70.57%
Other Assets $125.2M $36.62M
YoY Change 241.9% 76.86%
Total Long-Term Assets $5.086B $4.565B
YoY Change 11.4% 37.25%
TOTAL ASSETS
Total Short-Term Assets $5.720B $4.136B
Total Long-Term Assets $5.086B $4.565B
Total Assets $10.81B $8.701B
YoY Change 24.19% 27.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $172.0M $154.0M
YoY Change 11.69% 24.19%
Accrued Expenses $782.0M $538.0M
YoY Change 45.35% 23.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $1.417B $1.139B
YoY Change 24.47% 18.46%
LONG-TERM LIABILITIES
Long-Term Debt $707.0M $702.0M
YoY Change 0.71% 83.77%
Other Long-Term Liabilities $194.0M $125.2M
YoY Change 54.95% -7.72%
Total Long-Term Liabilities $194.0M $125.2M
YoY Change 54.95% -7.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.417B $1.139B
Total Long-Term Liabilities $194.0M $125.2M
Total Liabilities $2.937B $2.650B
YoY Change 10.86% 13.39%
SHAREHOLDERS EQUITY
Retained Earnings $4.434B $2.773B
YoY Change 59.88% 85.49%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $396.4M $316.2M
YoY Change 25.34% 0.06%
Treasury Stock Shares 3.990M shares 3.764M shares
Shareholders Equity $7.868B $6.052B
YoY Change
Total Liabilities & Shareholders Equity $10.81B $8.701B
YoY Change 24.19% 27.43%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income $594.7M $388.3M
YoY Change 53.15% 46.64%
Depreciation, Depletion And Amortization $35.40M $37.80M
YoY Change -6.35% 35.97%
Cash From Operating Activities $453.0M $414.9M
YoY Change 9.18% -36.27%
INVESTING ACTIVITIES
Capital Expenditures -$106.2M -$59.70M
YoY Change 77.89% -49.66%
Acquisitions
YoY Change
Other Investing Activities -$180.5M -$299.3M
YoY Change -39.69% 4.18%
Cash From Investing Activities -$286.7M -$358.8M
YoY Change -20.09% -11.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.700M -8.200M
YoY Change -145.12% -128.57%
NET CHANGE
Cash From Operating Activities 453.0M 414.9M
Cash From Investing Activities -286.7M -358.8M
Cash From Financing Activities 3.700M -8.200M
Net Change In Cash 170.0M 47.90M
YoY Change 254.91% -82.51%
FREE CASH FLOW
Cash From Operating Activities $453.0M $414.9M
Capital Expenditures -$106.2M -$59.70M
Free Cash Flow $559.2M $474.6M
YoY Change 17.83% -38.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS INC
dei Entity Small Business
EntitySmallBusiness
false
CY2016Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
28200000 USD
CY2017Q3 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
24500000 USD
CY2017Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
41800000 USD
CY2018Q3 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
40500000 USD
CY2017Q4 regn Capitalandfacilityleaseobligationsnoncurrent
Capitalandfacilityleaseobligationsnoncurrent
703453000 USD
CY2018Q3 regn Capitalandfacilityleaseobligationsnoncurrent
Capitalandfacilityleaseobligationsnoncurrent
707203000 USD
CY2016Q3 regn Loss Contingency Damages Soughtperunitproduced.
LossContingencyDamagesSoughtperunitproduced.
10000 EUR
CY2017Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
242014000 USD
CY2018Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
267937000 USD
CY2017Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
178183000 USD
CY2018Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
172361000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1538642000 USD
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1665737000 USD
CY2017Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
193684000 USD
CY2018Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
269271000 USD
CY2017Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
637162000 USD
CY2018Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
781924000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
640000 USD
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10519000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3512833000 USD
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3841174000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-284829000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-157778000 USD
CY2017Q4 us-gaap Assets
Assets
8764286000 USD
CY2018Q3 us-gaap Assets
Assets
10805613000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
4335030000 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
5719583000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2210000 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2342000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8926000 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
19652000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2027272000 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2851517000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1426773000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1729898000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
593783000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1104309000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2020556000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2834207000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
201200000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
792065000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
812733000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1087843000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
256862000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
275110000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
547703000 USD
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
804565000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
825233000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1100343000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
409804000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1061667000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
595748000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1619481000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
940747000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2749000000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
1036573000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2966661000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
326676000 USD
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
503282000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3583000 USD
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
8504000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1044084000 USD
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1425290000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5343000 USD
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
11148000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1370760000 USD
CY2018Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1928572000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
8926000 USD
CY2018Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
19652000 USD
CY2017Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
506291000 USD
CY2018Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
562818000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
110960000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
105441000 USD
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.66
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.06
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.84
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.14
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.313
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.327
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.065
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.135
CY2017Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
27700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
38900000 USD
CY2018Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
4900000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
21000000 USD
CY2017Q3 us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
CY2018Q3 us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
565605000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1523744000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
635861000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1877333000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
177288000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
498752000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41206000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
253286000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-28908000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
179852000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
359829000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
228605000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-59116000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-29462000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
108242000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
33521000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
235645000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
281624000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28209000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
87817000 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
6182000 USD
us-gaap Interest Expense
InterestExpense
19084000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
7494000 USD
us-gaap Interest Expense
InterestExpense
20851000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21791000 USD
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
28397000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
726138000 USD
CY2018Q3 us-gaap Inventory Net
InventoryNet
1039679000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
190045000 USD
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
216671000 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
302042000 USD
CY2018Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
435671000 USD
CY2018Q2 us-gaap Legal Fees
LegalFees
10500000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
2620208000 USD
CY2018Q3 us-gaap Liabilities
Liabilities
2937313000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8764286000 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10805613000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1135483000 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1417230000 USD
CY2016Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
10000000 EUR
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
596847000 USD
CY2018Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1104309000 USD
CY2017Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1486494000 USD
CY2018Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1873569000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
186135000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5934000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-669436000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1197093000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
740163000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1466269000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
388317000 USD
us-gaap Net Income Loss
NetIncomeLoss
1024992000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
594655000 USD
us-gaap Net Income Loss
NetIncomeLoss
1624047000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5679000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17036000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8938000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
60991000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
559926000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1540780000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
626923000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1816342000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77866000 USD
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
125197000 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
30000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
341000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2388000 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
21485000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
36645000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
752000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6954000 USD
CY2017Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
212260000 USD
CY2018Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
358940000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
152073000 USD
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
194033000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-44016000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
82694000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11861000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2048000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16432000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81842000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4378000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
77832000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
77096000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
883748000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1533558000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
164963000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
297638000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
224972000 USD
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
284807000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
226892000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
87408000 USD
us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
57000000 USD
us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
379275000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
644103000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2358605000 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2524446000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
19925000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
0 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
529749000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1547159000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
556972000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1584847000 USD
CY2017Q3 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2018Q3 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2946733000 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4433904000 USD
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1500673000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4289780000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1663496000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4783003000 USD
CY2017Q4 us-gaap Securities Owned Not Readily Marketable
SecuritiesOwnedNotReadilyMarketable
37500000 USD
CY2018Q3 us-gaap Securities Owned Not Readily Marketable
SecuritiesOwnedNotReadilyMarketable
45500000 USD
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
306766000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
910520000 USD
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
369232000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1064886000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
380144000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
300652000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
6144078000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
7868300000 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3763868 shares
CY2018Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
3990021 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
316240000 USD
CY2018Q3 us-gaap Treasury Stock Value
TreasuryStockValue
396371000 USD
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
45851000 USD
CY2017Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
75301000 USD
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
85302000 USD
CY2018Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
97090000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
295977000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
344313000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
266527000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
332525000 USD
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10322000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9886000 shares
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7055000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7015000 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117028000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115994000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115088000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114843000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106706000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106108000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108033000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107828000 shares
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Standards </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">. The new standard requires a lessee to recognize on its balance sheet (for both finance and operating leases) a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. The amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. We plan to adopt this new standard on January 1, 2019 (the "effective date") and use the effective date as our date of initial application. As such, we will not adjust prior period amounts. Furthermore, we expect to elect the practical expedients upon transition, which permit companies to not reassess lease identification, classification, and initial direct costs under the new standard for leases that commenced prior to the effective date. We are currently evaluating the impact that this guidance will have on our financial statements, including related disclosures. The new standard will result in the Company recording additional assets and corresponding liabilities related to operating leases; however, we do not expect the standard to have a material impact to our Consolidated Balance Sheets. The ultimate impact that the new standard will have will depend on the total amount of the Company's lease commitments as of the adoption date. We are in process of implementing a new lease accounting software system and updating our internal controls and processes.</font></div></div>

Files In Submission

Name View Source Status
0001532176-18-000036-index-headers.html Edgar Link pending
0001532176-18-000036-index.html Edgar Link pending
0001532176-18-000036.txt Edgar Link pending
0001532176-18-000036-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
regn-093018x10q.htm Edgar Link pending
regn-20180930.xml Edgar Link completed
regn-20180930.xsd Edgar Link pending
regn-20180930_cal.xml Edgar Link unprocessable
regn-20180930_def.xml Edgar Link unprocessable
regn-20180930_lab.xml Edgar Link unprocessable
regn-20180930_pre.xml Edgar Link unprocessable
regn-ex_311x09302018x10q.htm Edgar Link pending
regn-ex_312x09302018x10q.htm Edgar Link pending
regn-ex_32x09302018x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending